美国FDA批准的基于PFS的自动注射器:演变,市场趋势和发展挑战
Jeremy Guo1, Yueming Sun1, Duoduo Zhang1
1Global Drug Product Operations, WuXi Biologics Co., Ltd, Shanghai, China.
Expert opinion on drug delivery
|November 3, 2025
概括
预装注射器自注射器对于患者进行治疗至关重要. 本综述分析了自1980年以来FDA批准的设备,解决了改善未来自动注射器平台的技术挑战.
科学领域:
- 生物制药行业 生物制药行业
- 药物输送系统是药物输送系统.
- 医疗器械技术 医疗器械技术
背景情况:
- 患者自行注射的疗法越来越受青,特别是慢性疾病和免疫疗法.
- 基于预填注射器 (PFS) 的自动注射器由于方便和患者接受而被广泛采用.
- 在对一次性PFS自动注射器的全面审查中存在差距.
研究的目的:
- 系统地审查一次性预装注射器自动注射器.
- 分析自1980年以来FDA批准的自喷器产品.
- 讨论自动注射器配方开发中的技术挑战.
主要方法:
- 系统分析来自美国食品和药物管理局官方网站的数据.
- 自1980年以来,包括FDA批准的新药申请 (NDA) 和生物制品许可申请 (BLA).
- 审查将注射配方纳入弹驱动自动注射器系统的技术挑战.
主要成果:
- 确定FDA批准的一次性PFS自动注射器的趋势和关键特征.
- 分析自动注射器技术的发展和监管部门的批准.
- 在自动注射器开发中遇到的常见配方挑战的总结.
结论:
- 一次性预填注射器自注射器对于现代生物制药疗法至关重要.
- 对技术挑战的进一步研究可以带来改进的自动注射器设计.
- 增强的自喷器平台可以改善患者的体验和治疗坚持.
相关概念视频
FDA Approved Drugs: Changes to Approved Drugs
237
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
237
Drug Products: Biologics, Biosimilars and Interchangeables
223
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
223
Biopharmaceutical Factors Influencing Drug Product Design: Overview
227
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
227
Drug Administration and Therapy Phases: Overview
1.2K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.2K
Drug Delivery: Overview
714
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
714
Insulin Formulations: Types and Delivery
638
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
638


